BlackRock’s MDxHealth MDXH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$60.4K Buy
147,063
+42,742
+41% +$57.4K ﹤0.01% 5134
2026
Q1
$240K Buy
104,321
+5,138
+5% +$17.4K ﹤0.01% 4719
2025
Q4
$354K Buy
99,183
+482
+0.5% +$1.9K ﹤0.01% 4577
2025
Q3
$459K Buy
98,701
+13,183
+15% +$40.5K ﹤0.01% 4470
2025
Q2
$189K Buy
+85,518
New +$160K ﹤0.01% 4684

Other funds holding MDXH

BlackRock's MDXH Position: Q2 2026 in Review

BlackRock increased its MDxHealth (MDXH) stake by 41% in Q2 2026, buying an estimated $57.4K and bringing the position to 147,063 shares worth $60.4K. The position accounts for ﹤0.01% of the portfolio, ranked #5134.

BlackRock first reported a position in MDXH in Q2 2025 and has held it in 5 quarters since. The position peaked at $459K in Q3 2025. 26 funds tracked by Wall St. Rank hold MDXH as of Q2 2026.

  • BlackRock held 147,063 shares of MDxHealth worth $60.4K as of Q2 2026.
  • BlackRock bought 42,742 MDxHealth shares in Q2 2026, an estimated $57.4K.
  • MDxHealth made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #5134 holding.
  • BlackRock first reported a position in MDxHealth in Q2 2025 and has held it in 5 quarters since.
  • BlackRock's MDxHealth position peaked at $459K in Q3 2025.
  • 26 funds tracked by Wall St. Rank held MDxHealth as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.